Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 310

    1.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

    Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E.

    Diabetes Care. 1997 Sep;20(9):1353-6.PMID: 9283777 [PubMed - indexed for MEDLINE]Related articles

    2.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

    Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.

    Diabetes Care. 2004 Nov;27(11):2597-602.PMID: 15504992 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

    Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

    Lancet. 2008 May 24;371(9626):1753-60.PMID: 18502299 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes]

    Li YB, Zhu HL, Yao B, Huang ZM, Ou XZ, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):602-5. Chinese. PMID: 15949356 [PubMed - indexed for MEDLINE]Related articles

    5.

    Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.

    Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD.

    Diabetes Care. 2008 Oct;31(10):1927-32. Epub 2008 Jun 12.PMID: 18556343 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy.

    Park S, Choi SB.

    Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):124-30.PMID: 12673780 [PubMed - indexed for MEDLINE]Related articles

    7.

    Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

    Ryan EA, Imes S, Wallace C.

    Diabetes Care. 2004 May;27(5):1028-32.PMID: 15111515 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.

    Diabetes. 1999 Dec;48(12):2414-21.PMID: 10580431 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

    McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.

    Diabet Med. 2001 Jan;18(1):10-6.PMID: 11168335 [PubMed - indexed for MEDLINE]Related articles

    12.

    Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.

    Jennings AM, Lewis KS, Murdoch S, Talbot JF, Bradley C, Ward JD.

    Diabetes Care. 1991 Aug;14(8):738-44.PMID: 1954811 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.

    Hathout EH, McClintock T, Sharkey J, Kytsenko D, Hartwick N, Hadley-Scofield M, Torgeson S, Mace JW.

    Diabetes Technol Ther. 2003;5(2):175-81.PMID: 12871607 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    15.

    Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

    Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

    Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Insulin therapy in type 2 diabetes.

    Mudaliar S, Edelman SV.

    Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.PMID: 11727406 [PubMed - indexed for MEDLINE]Related articles

    17.

    Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

    Umpierrez GE, Clark WS, Steen MT.

    Diabetes Care. 1997 Apr;20(4):479-83.PMID: 9096964 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

    Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

    J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.PMID: 9398709 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Early and long-term effects of acute caloric deprivation in obese diabetic patients.

    Bauman WA, Schwartz E, Rose HG, Eisenstein HN, Johnson DW.

    Am J Med. 1988 Jul;85(1):38-46.PMID: 3291612 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data